Most patients who experience burning find it resolves spontaneously within minutes and does not recur with subsequent injections when technique is optimized
GLP-1 therapy requires sustained monitoring for pancreatitis risk, dehydration, rapid weight loss complications, and medication interactions
Stick with the classics like Ozempic and Mounjaro
Discontinuation rates due to adverse events in TRIUMPH-3 were 9.8% (9 mg) and 13.5% (12 mg) with retatrutide, compared with 4.8% for placebo
We also offer ongoing support and monitoring, including regular check-ins to assess progress and side effects, telemedicine options for convenient follow-ups, and access to a dedicated care team for questions and concerns
NICE technology appraisals: semaglutide (Wegovy) and tirzepatide (Mounjaro) for weight management